Sponsor & Developer Portfolio
Mahidol University
Clinical development pipeline, platform architecture, and registered trial tracking for Mahidol University vaccine candidates.
1
Candidates
1
Target Diseases
1
Linked Studies
Development Phase Distribution
Phase 3 Clinical Trial: 1
Platform Technologies
Biological (unspecified platform): 1
Target Pathogens & Indications
Diphtheria / Tetanus / Pertussis
Vaccine Pipeline Candidates (1)
Detailed candidate profiles, clinical phases, target indications, and anticipated milestones.
Phase 3 Clinical Trial
ctgov-pertagen-vaccine-mahidol-university
Adacel® vaccine
Target: Diphtheria / Tetanus / Pertussis
Platform: Biological (unspecified platform)
Key Milestone: Primary completion (most advanced trial): 2026-03 (registry estimate)
Explore Other Vaccine Developers & Sponsors
Compare pipeline volume, phase progression, and modalities across global biopharmaceutical manufacturers.